“Regional Impact of Prophylaxis With the Monoclonal Antibody Palivizumab on Ospitalizations from Respiratory Syncytial Virus in Infants”. 2001. Swiss Medical Weekly 131 (1112): 146-51. https://doi.org/10.4414/smw.2001.09681.